v3.25.2
Business Segments
 3 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280. Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. The primary measure used by our chief operating decision maker ("CODM") to evaluate the performance of our operating segments and allocate resources to these segments is contribution margin, which we define as gross profit less advertising and marketing expenses. Information regarding total assets by operating segment is not provided to our CODM. Our CODM is our Chief Executive Officer.

The tables below summarize information about our reportable segments.
 Three Months Ended June 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*212,578 $36,952 $249,530 
Cost of sales92,178 17,021 109,199 
Gross profit120,400 19,931 140,331 
Advertising and marketing28,954 5,983 34,937 
Contribution margin$91,446 $13,948 $105,394 
Other operating expenses 33,638 
Operating income $71,756 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.
 Three Months Ended June 30, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$232,316 $34,826 $267,142 
Cost of sales105,559 15,561 121,120 
Gross profit 126,757 19,265 146,022 
Advertising and marketing33,753 5,612 39,365 
Contribution margin$93,004 $13,653 $106,657 
Other operating expenses 34,611 
Operating income $72,046 
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.
The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended June 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$27,258 $1,674 $28,932 
Cough & Cold13,353 5,654 19,007 
Women's Health51,646 5,112 56,758 
Gastrointestinal43,696 14,088 57,784 
Eye & Ear Care27,781 4,527 32,308 
Dermatologicals27,852 2,257 30,109 
Oral Care18,154 3,548 21,702 
Other OTC2,838 92 2,930 
Total segment revenues$212,578 $36,952 $249,530 

Three Months Ended June 30, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$27,011 $1,282 $28,293 
Cough & Cold14,961 5,736 20,697 
Women's Health50,495 4,083 54,578 
Gastrointestinal44,287 13,728 58,015 
Eye & Ear Care43,319 4,811 48,130 
Dermatologicals31,603 1,752 33,355 
Oral Care17,674 3,100 20,774 
Other OTC2,966 334 3,300 
Total segment revenues$232,316 $34,826 $267,142